| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CIGNA CORPORATION | 65,000 | 9,364,000 | 4.79% | ||
| 2 | UNIVERSAL HLTH SVCS INC | 60,000 | 8,714,000 | 4.46% | ||
| 3 | TELEFLEX INC | 50,000 | 6,773,000 | 3.47% | Call | |
| 4 | TELEFLEX INC | 48,800 | 6,539,000 | 3.35% | ||
| 5 | ALIMERA SCIENCES INC | 1,243,807 | 5,995,000 | 3.07% | ||
| 6 | SIENTRA INC | 241,402 | 5,613,000 | 2.87% | ||
| 7 | NUVASIVE INC COM | 94,139 | 5,179,000 | 2.65% | ||
| 8 | PFIZER INC | 142,500 | 5,139,000 | 2.63% | ||
| 9 | STRYKER CORP | 50,000 | 5,114,000 | 2.62% | ||
| 10 | THERMO FISHER SCIENTIFIC INC | 37,500 | 4,866,000 | 2.49% | Call | |
| 11 | COOPER COS INC | 25,000 | 4,425,000 | 2.26% | ||
| 12 | SPECTRANETICS CORP | 250,000 | 4,275,000 | 2.19% | ||
| 13 | BOSTON SCIENTIFIC CORP | 235,000 | 4,075,000 | 2.09% | ||
| 14 | ABBVIE INC | 57,375 | 4,017,000 | 2.06% | ||
| 15 | SMITH & NEPHEW PLC SPDN ADR NEW | 105,000 | 3,886,000 | 1.99% | ||
| 16 | AGILENT TECHNOLOGIES INC | 100,000 | 3,858,000 | 1.97% | Call | |
| 17 | EDWARDS LIFESCIENCES CORP | 25,000 | 3,804,000 | 1.95% | ||
| 18 | VANDA PHARMACEUTICALS INC COM | 307,500 | 3,764,000 | 1.93% | ||
| 19 | NXSTAGE MED INC COM | 260,200 | 3,716,000 | 1.90% | ||
| 20 | OWENS & MINOR INC NEW | 105,000 | 3,692,000 | 1.89% | ||
| 21 | LIVANOVA PLC | 60,000 | 3,684,000 | 1.89% | ||
| 22 | JAZZ PHARMACEUTICALS PLC SHS USD | 18,000 | 3,460,000 | 1.77% | ||
| 23 | INSULET CORPORATION | 100,000 | 3,389,000 | 1.73% | ||
| 24 | CEPHEID | 60,000 | 3,335,000 | 1.71% | ||
| 25 | BRISTOL MYERS SQUIBB CO | 50,625 | 3,323,000 | 1.70% | ||
| 26 | PERRIGO CO PLC | 17,125 | 3,291,000 | 1.68% | ||
| 27 | AFFYMETRIX INCOC-CAP STK CASH MGREFF 4/1/16 1 OLDUSD 14.00 PER SHARE | 300,000 | 3,288,000 | 1.68% | ||
| 28 | VALEANT PHARMACEUTICALS INTL | 12,500 | 3,219,000 | 1.65% | ||
| 29 | CYNAPSUS THERAPEUTICS INC | 194,461 | 3,146,000 | 1.61% | ||
| 30 | WRIGHT MEDICAL GROUP NV | 120,101 | 3,103,000 | 1.59% | ||
| 31 | BIOGEN INC | 9,250 | 2,949,000 | 1.51% | ||
| 32 | PTC THERAPEUTICS INC | 60,000 | 2,888,000 | 1.48% | Put | |
| 33 | QIAGEN NV | 100,000 | 2,798,000 | 1.43% | ||
| 34 | KITE PHARMA INCORPORATED | 36,000 | 2,620,000 | 1.34% | ||
| 35 | FEI COMPANY | 30,000 | 2,579,000 | 1.32% | Call | |
| 36 | Receptos Inc | 11,000 | 2,506,000 | 1.28% | ||
| 37 | TRANSENTERIX INC | 762,000 | 2,492,000 | 1.28% | ||
| 38 | ALEXION PHARMACEUTIC | 12,500 | 2,468,000 | 1.26% | ||
| 39 | ACCURAY INCORPORATED COM | 380,000 | 2,424,000 | 1.24% | ||
| 40 | Allergan plc | 7,000 | 2,318,000 | 1.19% | ||
| 41 | SYNERGY PHARMACEUTICALS DEL COM NEW | 246,250 | 2,246,000 | 1.15% | ||
| 42 | LILLY ELI & CO | 26,500 | 2,240,000 | 1.15% | ||
| 43 | THORATEC LABS CORP | 50,000 | 2,229,000 | 1.14% | Put | |
| 44 | Wright Medical Group Inc | 585,536 | 2,172,000 | 1.11% | ||
| 45 | AKORN INC | 46,875 | 2,161,000 | 1.11% | ||
| 46 | Esperion Therapeutics Inc | 34,500 | 2,139,000 | 1.09% | Put | |
| 47 | ALLIQUA BIOMEDICAL INC | 420,000 | 2,092,000 | 1.07% | ||
| 48 | CATALYST PHARMACEUTICALS INC | 395,000 | 1,951,000 | 1.00% | ||
| 49 | SAGE THERAPEUTICS | 28,000 | 1,914,000 | 0.98% | ||
| 50 | SPECTRANETICS CORP | 75,000 | 1,726,000 | 0.88% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000909012-15-000275, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
